In AML, hexokinase 2 (HK2) can localize to the nucleus, and interact with nuclear proteins to maintain stemness.[24] As a critical catalytic enzyme in the glycolytic pathway, ALDOA participates in cancer development through diverse mechanisms in the tumor microenvironment. This evidence concerns the gene HK2 and acute myeloid leukemia.